Aida Announces New Anti-Cancer Drug Under D...(02 certified for quality assuranceand IS...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Aida Announces New Anti-Cancer Drug Under Development
Date:4/18/2008
02 certified for quality assurance and ISO14000 certified for ecologically-friendly practices.
For additional information, please visit http://en.aidapharma.com.
Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
'/>"/>
| SOURCE Aida Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:11/20/2008)...wswire/ -- Milk. It does a body good. And,now it,...ter years of,research, scientists at OncoNutritio...k that stimulate the body,s own production of anti... Release, go to:, http://www.prnewswire.com/mnr/eq...w cancer therapies, the chief scientist, Dr. David...
(Date:11/20/2008)...swire/ -- Radius Health ("Radius") announced today...ts second institutional financing round, increasin...he total amount raised since the company,s incepti...nvestors participated in the financing, led by MPM...al, The Wellcome Trust, HealthCare Ventures, Oxfor...
(Date:11/20/2008)... The Scandinavian-based drug,devel...ts of studies on its,lead antimicrobial candidate...he studies showed that the novel lytic peptidomime...ificantly better towards killing Staphylococcus,a...d standard drugs. In,addition to this it has prov...
(Date:11/19/2008)...e statistical significance , , ISELIN, N.J....ration (Nasdaq: PARS ) today announced results f...oEmulsion (NE) drug delivery technology formulated... multi-center, randomized, double-blinded, placebo...y of the Company,s 3% Diclofenac Diethanolamine Na...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Experimental Drug Fights Prostate Cancer 5747 1Experimental Drug Fights Prostate Cancer 5747 2Tweens double use of diabetes drugs 5745 1Tweens double use of diabetes drugs 5745 2Higher levels of pollutants found in fish caught near a coal fired power plant 5743 1Higher levels of pollutants found in fish caught near a coal fired power plant 5743 2HCA Reports Third Quarter 2007 Results 5741 1HCA Reports Third Quarter 2007 Results 5741 2HCA Reports Third Quarter 2007 Results 5741 3HCA Reports Third Quarter 2007 Results 5741 4HCA Reports Third Quarter 2007 Results 5741 5HCA Reports Third Quarter 2007 Results 5741 6HCA Reports Third Quarter 2007 Results 5741 7HCA Reports Third Quarter 2007 Results 5741 8HCA Reports Third Quarter 2007 Results 5741 9HCA Reports Third Quarter 2007 Results 5741 10HCA Reports Third Quarter 2007 Results 5741 11HCA Reports Third Quarter 2007 Results 5741 12HCA Reports Third Quarter 2007 Results 5741 13HCA Reports Third Quarter 2007 Results 5741 14[0] Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects[0] Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million[0] Lytix Presents LTX-109 Anti-Microbial Data at ICAAC[0] Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
...NESS WIRE)--Mar 20, 2007 - Arrowhead,Research Corp...y-owned subsidiary Calando Pharmaceuticals has pub...Academy of Sciences,(PNAS) of the first non-human ...h Calando,s lead siRNA therapeutic candidate., Cal...eted,polymeric delivery systems and siRNA design t...
...20, 2007 /PRNewswire/ -- Treatment of,coronary art... the,inpatient setting, according to a study publi..., U.S. hospitalization rates for heart attacks (ac...from 2002 to 2005, possibly due,to broader use of ...irin, as well as declines in risk factors like smo...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3(Date:11/21/2008)...archers remain cautious about future antibiotic re...Y, Nov. 21 (HealthDay News) -- People with moderat...(COPD) may be able to reduce the frequency of exac...antibiotic, a new report says. , The study, pu...erican Journal of Respiratory and Critical Care Me...
(Date:11/21/2008)... Nov. 21 The Universit...e beginning of a collaborative effort to eradicate...or Breast Cancer Awareness and Research of the Ame... Lady of the United States, and Vivian Fernandez d...oining M. D. Anderson in the initiative are the U....
(Date:11/21/2008)...areholders Intend To Vigorously Protect Investment...TI, Nov. 21 Dr. Stephen...n amendment to their Schedule 13D with the U.S. Se...ously filed a 13D disclosing ownership of 11.4% of...s 77 LasikPlus fixed-site laser vision correction ...
(Date:11/21/2008)... LAKES, N.J., Nov. 21 To...edical intervention in treating 88 percent of pati... of Americans treated for a chronic condition acco...ng and 75 percent of all medical costs. A proprie... by Medco Health Solutions, Inc. (NYSE: MHS ) si...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6[0] Long-Term Erythromycin Cut COPD Complications [0] First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama[0] Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company[0] New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
...-Sinai Medical Center this week launched an Intern...duct both adult and embryonic stem cell research. ...arrival of renowned Israeli developmental genetici...the institute’s co-director along with David I. Me...
... temperatures have been on an all time high in the...keeping tabs on the rising temperature and polluti...during the period from 15th to 19th July, the temp...ong with nitrogen dioxide pollution, which is know...
...nt investigation reveals that vocal cord dysfuncti... M. Weinberger, of the University of Iowa,// and h...s who were reported to be suffering from this dysf...patients, 41 were reported to be suffering from as...
... 40 percent of female German smokers refuse to qui...tive study by the Instituts Gewis for the Hamburg-...ed, 39 percent of those between ages 25 and 39 rep...n weight." Experts disagree. Most smokers do gain...
Other Medicine News:Health News:Center Launches New International Stem Cell Research Institute 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)
...ing of tube racks. Its camera-based vision system ... per rack, making it ideal for use in automated se... rack to be read automatically and can be easily a...prevents a rack from being read in the wrong orien...
Polypropylene workbench top with powder-coated steel legs. Height is adjustable from 25"-34". Available in hundreds of sizes and configurations. Accessories include shelves, drawers, light fixtures a
Perforated or Rod Top, Free Standing or Wall Mounted, Storage Cubby Optional, Polypropylene Construction
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |